Alta Life Sciences invests in Inbiomotion
Alta Life Sciences has led an investment round for Barcelona-based Inbiomotion, a biotech company specialising in diagnostics for breast cancer.
More on Early-stage
Blue Horizon leads $10m extended series-B for Mosa Meat
New round brings the total capital raised at series-B stage to $85m
Industrifonden leads €4.6m extended series-A for EnginZyme
Latest round brings company's total series-A funding to €11m
Braavos leads SpyBiotech's $32.5m series-A
Proceeds will advance the clinical development of SpyBiotech's vaccine technology platform
Kurma et al. invest in MedLumics
Investment is part of a larger round led by Asabys Partners, along with VI Partners and CDTI Innvierte
Latest News
August Equity hires Walsh, Stevens and Coates
UK-based PE firm August Equity hires Greg Walsh, Mark Stevens and Michael Coates
Apax buys 17% stake in EQT's Idealista for €250m
Deal takes place just a few months months after Apax sold its majority stake in the business to EQT
Eurocov buys KTN out of administration
Entrepreneur Philipp Mühlbauer's investment holding will buy KTN following an administration process
QPE hires three
Queen's Park Equity has hired Alison Price, Valentina Matheus and Prudence Jones